Compounds > docetaxel anhydrous
Page last updated: 2024-09-04

docetaxel anhydrous and Disease Models, Animal

docetaxel anhydrous has been researched along with Disease Models, Animal in 134 studies

Research

Studies (134)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (2.99)18.2507
2000's27 (20.15)29.6817
2010's81 (60.45)24.3611
2020's22 (16.42)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Han, R; Hao, Y; Hu, D; Liu, Q; Lu, Y; Peng, J; Qian, Z; Xiao, Y; Yuan, L1
Dai, J; Escara-Wilke, J; Keller, ET; Robinson, T; Zimmermann, J1
Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H1
Callan, B; Callan, JF; Kelly, P; Logan, K; McHale, AP; McKaig, T; McKeown, S; Nesbitt, H; O'Rourke, D; O'Sullivan, JM1
Chen, B; Din, J; Fu, W; Hong, Z; Li, Q; You, X; Yuan, G; Zhao, B1
Jang, SJ; Jo, SY; Lee, A; Lee, B; Lee, CH; Lee, SH; Mun, H; Oh, JH; Suh, YA1
Cui, P; Hu, Y; Liu, J; Liu, T; Liu, X; Lu, X; Lu, Y; Piao, C; Wang, Y; Xiao, M; Xu, X; Zhang, Q1
Fan, R; Guo, J; Hu, Z; Li, T; Wang, C; Yang, J; Zeng, C1
Chen, X; Ge, X; Qin, W; Shi, C; Tan, D; Wu, P; Xu, R; Zhang, C; Zhao, Y1
Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O1
Andrade, BYG; Báo, SN; da Rocha, MCO; da Silva, PB; de Oliveira, JV; Estrela-Lopis, I; Longo, JPF; Merker, C; Radicchi, MA; Venus, T1
Cao, W; Cui, D; Hou, N; Li, W; Liu, B; Liu, Y; Tan, H; Wang, Z; Xu, B; Zheng, D1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z1
Bathara, M; Chaudhari, D; Date, T; Ghadi, R; Jain, S; Kuche, K1
Anisimov, VN; Artemyeva, AS; Baldueva, IA; Belyaev, AM; Golubev, AG; Kireeva, GS; Kruglov, SS; Maydin, MA; Panchenko, AV; Tyndyk, ML1
Batra, SK; Das, A; Datta, K; Halder, S; Islam, R; Kshirsagar, P; Kukreja, RC; Mallya, K; Muniyan, S; Parte, S; Rachagani, S; Rauth, S; Seshacharyulu, P; Siddiqui, JA; Teply, BA; Vengoji, R; Xi, L1
Emami, J; Hasanzadeh, F; Kazemi, M; Lavasanifar, A; Minaiyan, M; Mirian, M; Mokhtari, M1
Hirayama, A; Hirose, F; Iwata, S; Kawabata, Y; Oike, A; Osaki, A; Sanematsu, K; Shigemura, N; Takai, S; Wada, N; Watanabe, Y; Yamada, Y; Yamazoe, J1
Ajani, JA; Bhutani, M; Chen, Q; Correa, A; Estrella, JS; Gan, B; Hofstetter, WL; Huo, L; Jin, J; Johnson, RL; Lee, JH; Lei, G; Li, CY; Li, Y; Liu, B; Ma, L; Pizzi, MP; Scott, A; Shanbhag, N; Song, S; Wang, Y; Wei, S; Weston, B; Xiao, L1
Cook, LM; Frieling, JS; Lawrence, HR; Lawrence, NJ; Li, T; Lo, CH; Lynch, CC; McGuire, JJ; Muhammad, A1
Aronen, H; Jambor, I; Laakso, H; Liimatainen, T; Liljenbäck, H; Merisaari, H; Minn, H; Poutanen, M; Roivainen, A; Sierra, A; Virtanen, H; Ylä-Herttuala, E1
Hiraiwa, R; Iguma, Y; Imai, S; Iwamitsu, Y; Kawaguchi-Sakita, N; Kotake, T; Koyanagi, M; Matsubara, K; Matsumoto, M; Nagayasu, K; Nakagawa, S; Nakagawa, T; Ntogwa, M; Ogihara, T; Omura, T; Saigo, M; Yonezawa, A1
Girgis-Gabardo, A; Gwynne, WD; Hassell, JA; Shakeel, MS1
Jang, EJ; Jin Hyung, W; Kim, H; Kyu Choi, D; Kyum Kim, S; Lim, SJ; Seok Lim, J1
Chao, TI; Chen, KF; Chen, MH; Chu, PY; Huang, CT; Huang, TT; Lau, KY; Lee, CH; Liu, CY; Shiau, CW; Su, JC; Tsai, WC; Tseng, LM; Wang, WL; Wu, CY; Yang, HP1
Alshaker, H; Chao, Y; Cooper, C; Pchejetski, D; Srivats, S; Wang, Q1
Alshaker, H; Böhler, T; Chao, Y; Cooper, C; Pchejetski, D; Srivats, S; Wang, Q1
Adena, SKR; Mishra, B; Mittal, P; Upadhyay, M; Vardhan, H; Yadav, SK1
He, MF; Li, CY; Shen, LZ; Tan, AM; Wei, P; Wu, JQ; Zhai, J1
Chen, JS; Gao, HT; Gu, JF; Li, JD; Li, W; Liu, KL; Qu, CB; Wang, XL; Wen, JK; Yang, Z; Zhang, ML; Zhang, Y; Zhang, YP; Zheng, B1
Algarra, I; Chamorro, V; Collado, A; Garcia-Lora, AM; Garrido, C; Garrido, F; Romero, I1
Bora, C; Candiloro, KM; Coleman, TP; Connolly, DC; Davis, B; Galati, CA; Ganta, S; Litwin, S; Maglaty, MA; Morse, AB; Nack, AH; O'Brien, SW; Patel, NR; Piroyan, A; Solon, AL1
Chung, SK; Dong, CM; Ho, LC; Huang, YH; Lai, CSW; Li, Q; Sham, PC; Shi, DD; Wang, XM; Wu, EX; Zhang, ZJ1
Astone, M; Beigh, FH; Deng, Y; Ferrari, MG; Ganaie, AA; Hoeppner, LH; Hussain, T; Konety, BR; Koochekpour, S; Maqbool, R; Morrissey, C; Murugan, P; Parray, AS; Saleem, M; Siddique, HR; Umbreen, S1
Fan, D; Liu, Y1
Bieblová, J; Hodný, Z; Mikyšková, R; Mrázková, B; Reiniš, M; Sapega, O1
Guido, MC; Kalil-Filho, R; Maranhão, RC; Meneghini, BC; Stefani, HA; Tavares, ER; Tavoni, TM1
Li, H; Li, X; Lv, M; Qiao, B1
Askoxylakis, V; Blaydes, R; Drummond, DC; Dumont, N; Geddie, ML; Grabow, S; Hayes, ME; Huang, ZR; Kamoun, WS; Kim, J; Kirpotin, DB; Kohli, N; Kornaga, T; Koshkaryev, A; Kuesters, G; Lugovskoy, AA; Luus, L; Marks, JD; Noble, CO; Olivier, K; Oyama, S; Pien, C; Reynolds, CP; Sawyer, AJ; Schihl, SA; Suchy, J; Tipparaju, SK; Wilton, JH; Zhou, Y1
Cai, SQ; Qiang, JW; Qiao, TK; Yuan, SJ1
Ahmed, AA; Dai, J; Escara-Wilke, J; Keller, ET; Palande, M; Robinson, T1
Chang, SF; Godec, A; Hawkins, WG; Hirbe, AC; Prudner, BC; Rathore, R; Robinson, AM; Van Tine, BA1
Baş, E; Nazıroğlu, M1
Cao, F; Chen, D; Chen, L; Feng, J; Wang, R; Yan, F; Yu, C; Yu, Z; Zhang, X; Zhu, H1
Barangi, M; Bouvet, M; Chawla, SP; Endo, I; Higuchi, T; Hiroshima, Y; Hoffman, RM; Homma, Y; Katsuya, Y; Li, Y; Matsuyama, R; Miyake, K; Murakami, T; Nelson, SD; Oshiro, H; Park, JH; Razmjooei, S; Singh, SR; Sugisawa, N; Zhang, Z1
Field, CJ; Goruk, S; Mazurak, V; Newell, M; Postovit, L1
Calleja-Cervantes, ME; Collado-Sole, A; Diaz-Lagares, A; Dobrolecki, LE; Eroles, P; Esteller, M; Gómez, A; Gómez-Miragaya, J; González-Suárez, E; Lewis, MT; Morán, S; Paré, L; Prat, A; Serra, V1
Agarwal, A; Aljumaily, R; Covic, L; Kaimal, R; Kim, YB; Kuliopulos, A; Pradhan, RV; Sharifi, S; Tressel, SL; Zarwan, C1
Abate-Shen, C; Benson, M; Delto, JC; Kobayashi, T; McKiernan, J1
Bissery, MC; Bouchard, H; Calvet, L; Combeau, C; Commerçon, A; Lavelle, F; Lejeune, P; Riou, JF; Sémiond, D; Vrignaud, P1
Fujita, K; Hatano, K; Kaneda, Y; Murakami, K; Nagahara, A; Nakai, Y; Nakayama, M; Nimura, K; Nonomura, N; Tsuchiya, M; Uemura, M; Yamaguchi, S1
Awasthi, N; Hinz, S; Schwarz, AM; Schwarz, MA; Schwarz, RE; Wang, C; Williams, NS; Zhang, C1
Ernsting, MJ; Foltz, WD; Holwell, N; Li, SD; Murakami, M; Undzys, E1
Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Yasumizu, Y1
La Flamme, AC; Miller, JH; Northcote, PT; O'Sullivan, D1
Bai, Y; Davies, BR; Han, S; Ji, Q; Li, J; Liu, YJ; Tang, L; Wang, H; Xu, Y; Yin, X; Yu, DH; Zhang, J; Zhou, M1
Corey, E; Giannakakou, P; Matov, A; Nanus, DM; Plymate, SR; Portella, L; Sun, S; Sung, M; Thadani-Mulero, M; Vessella, RL1
Bobilev, D; Ditzler, S; Eslamy, H; Girard, E; Lee, D; Olson, J; Park, J; Richards, A; Vrignaud, P; Yagle, K1
Azuma, H; Cox, ME; Fazli, L; Ghaffari, M; Gleave, ME; Ibuki, N; Levitzki, A; Pandey, M; Reuveni, H1
Chen, H; Huang, L; Liang, X; Liu, Z; Mei, L; Tao, W; Xiao, X; Yang, Y; Zeng, X; Zhang, X1
Chong, T; Fu, D; Li, H; Wang, Z; Zhang, H1
Bu, ZF; Cao, PC; Li, AJ; Liu, GD; Liu, WS; Zheng, YH1
de Morrée, ES; de Ridder, CMA; de Wit, R; Kweldam, CF; Mathijssen, RHJ; van Soest, RJ; van Weerden, WM; Wiemer, EAC1
Gao, Z; Jiang, C; Jin, M; Li, P; Li, Y1
Demir, N; Erin, N; Kale, Ş; Köksoy, S; Korcum, AF; Tanrıöver, G1
Alva, AS; Boes, JL; Brisset, JC; Chenevert, TL; Galbán, CJ; Galbán, S; Hoff, BA; Hussain, M; Jacobson, JA; Johnson, TD; Meyer, CR; Nicolay, K; Pienta, KJ; Rehemtulla, A; Ross, BD; Schakel, T1
Callaghan, CK; O'Mara, SM1
Dams-Kozłowska, H; Dondajewska, E; Kazimierczak, U; Kotlarski, M; Kozłowska, A; Kwiatkowska, E; Mackiewicz, A; Mackiewicz, J; Nowicka-Kotlarska, A; Wysocki, PJ1
Boon, U; Buijsman, RC; de Man, J; de Roos, JA; Janssen, A; Jonkers, J; Kops, GJ; Maia, AR; Medema, RH; Omerzu, M; Prinsen, MB; Song, JY; Sterrenburg, JG; Uitdehaag, JC; van Doornmalen, AM; Willemsen-Seegers, N; Zaman, GJ1
Nakashima, T; Sakurai, K; Sasabe, H; Sato, A; Sato, M; Shibamori, M; Uematsu, N; Umehara, K; Yamamura, Y1
Angsantikul, P; Carpenter, C; Chen, TC; Chien, S; Dehaini, D; Fang, RH; Gao, W; Hofman, FM; Hu, CM; Kroll, AV; Luk, BT; Nguyen, P; Patel, SH; Qu, V; Ramesh, M; Shi, W; Thamphiwatana, S; Wang, KC; Wen, CH; Zhang, K; Zhang, L; Zhu, J1
Fazli, L; Gleave, M; Hernandez, E; Hsieh, JT; Lin, CJ; Yun, EJ; Zhou, J1
Beijnen, JH; Hendrikx, JJ; Huitema, AD; Rottenberg, S; Schellens, JH; Yu, H1
Jin, Z; Li, B; Li, H; Liu, C; Ou, X; Xu, Y; Zhang, Y; Zhou, H1
Adediran, S; Choi, EY; Dan, HC; Hussain, A; Lapidus, RG; Liu, P; Liu, X; Wang, X; Zhang, Y1
Cun, X; Gao, H; He, Q; Hu, C; Hu, G; Kuang, Q; Ruan, S; Shi, K; Wang, Y; Xiao, W1
Benjamin, CJ; Chokshi, S; Chung, PH; Dreher, MR; Linehan, WM; Negussie, AH; Pinto, PA; Ranjan, A; Volkin, D; Wood, BJ; Yeram, N1
Chang, C; Cui, Y; Hu, S; Jin, J; Li, L; Li, X; Luo, J; Sun, Y; Yeh, S1
Choi, EK; Chung, HK; Jeong, SY; Jung, J; Jung, KH; Kim, KP; Lee, JS; Lee, SW; Park, J; Seo, MH; Song, SY1
Du, M; Kohli, M; Lieberman, R; Meng, H; Nevalainen, M; Pan, J; Shenoy, NK; Wang, L; Wang, Y; You, M; Zhang, P; Zhang, Q1
Dang, Z; Du, J; Feng, J; Hu, K; Liu, H; Tu, L; Wang, L; Zhou, Y1
Chlopicki, S; Denslow, A; Gebicki, J; Maciejewska, M; Marcinek, A; Nowak, M; Switalska, M; Wietrzyk, J1
Ensley, JF; Kim, H; Kucuk, O; Lin, HS; Lonardo, F; Piechocki, MP; Stevens, T; Subramanian, G; Tulunay, OE; Won, J; Yoo, GH1
Ebetino, FH; Lowik, CW; Papapoulos, SE; van Beek, ER; van Wijngaarden, J1
Croyle, MA; Dekker, JD; Strychor, S; Wonganan, P; Zamboni, WC1
Bologna, M; D'Alessandro, AM; Dolo, V; Festuccia, C; Gravina, GL; Millimaggi, D; Muzi, P; Ricevuto, E; Vicentini, C1
Hasegawa, S; Kimura, S; Maekawa, T; Matsumoto, S; Sato, K; Tanaka, F; Wada, H1
Bianchi, R; Camozzi, F; Carozzi, V; Cavaletti, G; Cervellini, I; Crippa, D; Lauria, G; Melcangi, RC; Roglio, I1
Chen, Z; Corey, DR; Hsieh, JT; Koeneman, KS; Li, Y; Li, ZZ; Malaeb, BS; Shay, JW; Thompson, MG1
Da Silva, SV; Faure, F; Jakob, I; Pasquis, B; Sicard, G1
Ichibangase, T; Imai, K; Kishikawa, N; Kuroda, N; Nakashima, K; Ohyama, K; To, H; Tomonari, M1
Allen, CJ; De Souza, R; Moriyama, EH; Piquette-Miller, M; Wilson, BC; Zahedi, P1
Aguilar-Mahecha, A; Alsawafi, Y; Basik, M; Buchanan, M; Gaboury, L; Hassan, S; Jahan, K; Mourskaia, AA; Muller, WJ; Salvucci, O; Siegel, PM1
Dence, C; Fujibayashi, Y; Hasegawa, Y; Kiyono, Y; Kobayashi, M; Oyama, N; Ponde, DE; Welch, MJ; Yokoyama, O1
Bottsford-Miller, J; Broaddus, RR; Bruckheimer, E; Coffey, D; Coffman, K; Coleman, RL; Gershenson, DM; Han, LY; Hwang, JY; Kamat, AA; Landen, CN; Lin, YG; Lu, C; Merritt, WM; Nick, AM; Nugent, E; Sood, AK; Spannuth, WA; Stone, RL1
Horiuchi, A; Kikuchi, S; Kojima, Y; Kuwabara, J; Matsuno, Y; Morimoto, M; Sato, K; Sato, M; Sugishita, H; Watanabe, Y; Yamamoto, Y; Yoshida, M1
Beekman, CA; Buckle, T; Rottenberg, S; Valdés Olmos, RA; van Leeuwen, AC; van Leeuwen, FW; Verheij, M1
Brooks, DE; Burt, HM; Chafeeva, I; Gleave, ME; Heller, L; Heller, M; Matsui, Y; Mugabe, C; So, AI; Zeisser-Labouèbe, M1
Anantha, M; Bally, MB; Kalra, J; Masin, D; Osooly, M; Strut, D; Warburton, C; Waterhouse, D; Yan, H; Yang, YJ1
Beretov, J; Chao, H; Chen, H; Hao, J; Kearsley, JH; Li, Y; Perkins, AC; Pourgholami, MH; Wang, L1
Adams, M; Bartlett, JB; Dalgleish, AG; Galustian, C; Henry, JY; Lu, L; Meyer, B1
Baker, JH; Brooks, DE; Burt, HM; Fazli, L; Gleave, ME; Jackson, JK; Liggins, RT; Minchinton, AI; Mugabe, C; Raven, PA; So, AI1
Ernsting, MJ; Li, SD; MacCallum, NW; Tang, WL1
Ernsting, MJ; Foltz, WD; Li, SD; Tagami, T; Undzys, E1
Altabef, A; Bardeesy, N; Butaney, M; Cameron, MD; Cantley, LC; Castrillon, DH; Chen, Z; Cheng, K; Chirieac, LR; Costa, DB; Demetri, GD; Ebi, H; Engelman, JA; Franchetti, Y; Gao, P; Hayes, DN; Jackman, D; Jänne, PA; Kung, AL; Lee, C; Lee, CB; Li, J; Liu, Y; Nakada, Y; Nishino, M; Ouyang, J; Pandolfi, PP; Peña, CG; Roberts, PJ; Saur, A; Sharpless, NE; Shimamura, T; Sun, Y; Tupper, T; Walton, Z; Wang, S; Wang, Y; Wilkerson, MD; Wong, KK; Woo, MS; Xu, C; Yanagita, M; Yao, C1
Johnson, L1
Chang, JC; Dave, B; Dobrolecki, LE; Hilsenbeck, SG; Landis, MD; Lewis, MT; Liu, D; Tweardy, DJ; Westbrook, TF; Wu, MF; Zhang, X1
Kawai, N; Kobayashi, D; Kobayashi, T; Kohri, K; Naiki, T; Sato, S; Takahashi, S; Tozawa, K; Yamada, K; Yasui, T1
Cao, Q; Choy, H; Kim, JC; Saha, D1
Beryt, M; Konecny, GE; O'Callaghan, C; Pegram, MD; Pietras, R; Slamon, DJ1
Glehen, O; Mohamed, F; Stuart, OA; Sugarbaker, PH; Urano, M1
Higgins, SA; Liu, Y; Rockwell, S1
Badve, S; Campbell, RA; Kumar, S; Mehrotra, S; Murry, DJ; Nakshatri, H; Roman, Y; Sadaria, MR; Sheridan, C; Shortle, NH; Sweeney, CJ1
Lathers, DM; Young, MR1
Bonhoure, E; Calvet, C; Cuvillier, O; Doumerc, N; Garcia, V; Golzio, M; Malavaud, B; Mazerolles, C; Pchejetski, D; Rischmann, P; Teissié, J1
Brodie, AM; Goloubeva, O; Hussain, A; Jelovac, D; Khan, MA; Lee, DI; Tang, Y1
Baxter, M; Beyer, C; Discafani, C; Greenberger, LM; Hari, M; Liu, H; Rios, C; Sampath, D; Yang, S1
de las Pozas, A; Perez-Stable, C; Reiner, T1
Agrawal, S; Cherton-Horvat, GG; Durkin, JP; Gillard, JW; Hewitt, KE; Jerome, LJ; Kandimalla, ER; LaCasse, EC; Morris, SJ; Wang, H; Wang, W; Yu, D; Zhang, R1
Coleman, I; Haugk, K; Ludwig, DL; Montgomery, RB; Nelson, P; Plymate, SR; Vessella, R; Woodke, L; Wu, JD1
Chao, KS1
Assayag, F; Auger, N; de Cremoux, P; De Pinieux, G; de Plater, L; Degeorges, A; Delattre, O; Diéras, V; Guyader, C; Judde, JG; Marangoni, E; Poupon, MF; Rebucci, M; Sastre-Garau, X; Sigal-Zafrani, B; Tran-Perennou, C; Vincent-Salomon, A1
Chen, J; Fujiwara, T; Huang, P; Kaku, H; Kashiwakura, Y; Kumon, H; Nasu, Y; Saika, T; Urata, Y; Watanabe, M1
Bar-Eli, MM; De Geest, K; Fletcher, MS; Han, LY; Jennings, N; Kamat, AA; Landen, CN; Langley, RR; Lin, YG; Lopez-Berestein, G; Lutgendorf, SK; Merritt, WM; Sanguino, A; Sood, AK; Spannuth, WA; Villares, G1
Dai, JL; Daignault, S; Day, ML; Dougall, W; Escara-Wilke, JF; Ignatoski, KM; Keller, ET; Lui, A; Sargent, EE; Yao, Z; Zhang, J1
Hortobágyi, G1
Burris, HA1
Asano, S; Hibino, H; Ikebuchi, K; Nakahata, T; Nakazaki, Y; Sugimoto, Y; Sugiyama, H; Suzuki, S; Takahashi, S; Tanabe, T; Tani, K; Tanioka, Y; Tojo, A; Wu, MS1
Arakawa, H; Harada, N; Hashiyama, T; Nakanishi, N; Oda, K; Ozaki, K; Tsujihara, K; Yamaguchi, T1
Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T1
Bittner, C; Feyerabend, T; Peters, SO; Raap, M; Remmert, S; Robins, IH; Sieg, P; Sommer, K; Wiedemann, GJ1
Alila, H; Bunn, PA; Chan, DC; Earle, K; Helfrich, B; Kelly, K; Pamukcu, R; Piazza, G; Thompson, W; Whitehead, CM; Zhao, TL1
Larsson, LI; Lichtenberg, J1

Reviews

6 review(s) available for docetaxel anhydrous and Disease Models, Animal

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
The Role of Serotonin in Breast Cancer Stem Cells.
    Molecules (Basel, Switzerland), 2021, May-26, Volume: 26, Issue:11

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Docetaxel; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Phenotype; Receptors, Serotonin; Remission Induction; Serotonin; Sertraline; Signal Transduction

2021
Docetaxel in breast cancer and a rationale for combination therapy.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Mice; Paclitaxel; Taxoids

1997
Docetaxel in combination with fluorouracil for advanced solid tumors.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8

    Topics: Adult; Aged; Animals; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Mice; Middle Aged; Mucous Membrane; Neoplasms; Neutropenia; Paclitaxel; Taxoids

1997
Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
    Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 4

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Disease Models, Animal; Docetaxel; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Paclitaxel; Rats; Sulindac; Survival Analysis; Taxoids; Treatment Outcome; Tumor Cells, Cultured

2002

Trials

5 trial(s) available for docetaxel anhydrous and Disease Models, Animal

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
    Gut, 2021, Volume: 70, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Esophageal Neoplasms; Female; Gossypol; Humans; Male; Mice; Middle Aged; Neoplastic Stem Cells; Pilot Projects; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms

2021
Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Animals; Antineoplastic Agents; Bone Density; Bone Neoplasms; Diffusion Magnetic Resonance Imaging; Diphosphonates; Disease Models, Animal; Docetaxel; Humans; Male; Mice; Multimodal Imaging; Osteoblasts; Osteolysis; Prostatic Neoplasms; Taxoids; Treatment Outcome; Tumor Burden

2015
Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model.
    Oncotarget, 2016, Nov-22, Volume: 7, Issue:47

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Male; Maximum Tolerated Dose; Mice; Middle Aged; Nanoparticles; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Polymers; Taxoids; Treatment Outcome; Tubulin Modulators; Tumor Burden; Xenograft Model Antitumor Assays

2016

Other Studies

125 other study(ies) available for docetaxel anhydrous and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:24

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Caco-2 Cells; Colorectal Neoplasms; Disease Models, Animal; Docetaxel; Female; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Micelles

2021
A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis.
    The Prostate, 2023, Volume: 83, Issue:13

    Topics: Animals; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Humans; Interleukin-2; Ki-67 Antigen; Male; Mice; Prostatic Neoplasms; Receptors, CXCR4; Tartrate-Resistant Acid Phosphatase

2023
Ultrasound targeted microbubble destruction using docetaxel and Rose Bengal loaded Microbubbles for targeted Chemo-Sonodynamic therapy treatment of prostate cancer.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2023, Volume: 192

    Topics: Aged; Androgen Antagonists; Androgens; Animals; Disease Models, Animal; Docetaxel; Humans; Male; Mice; Microbubbles; Prostatic Neoplasms; Rose Bengal

2023
Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 118

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Gene Ontology; Gene Regulatory Networks; Male; Mice, Nude; MicroRNAs; Prostatic Neoplasms, Castration-Resistant

2019
Taxotere Induces Dephosphorylation of MET in Patient-derived Tumor Models.
    Anticancer research, 2020, Volume: 40, Issue:1

    Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Humans; Mice; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-met; Signal Transduction; Xenograft Model Antitumor Assays

2020
Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model.
    Cellular immunology, 2020, Volume: 348

    Topics: Adoptive Transfer; Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Humans; Immunosuppression Therapy; Male; Mice; Mice, Inbred BALB C; Myeloid-Derived Suppressor Cells; Neoplasms, Experimental; T-Lymphocytes

2020
PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation.
    Biomaterials science, 2020, Mar-07, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contrast Media; Disease Models, Animal; Docetaxel; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Microbubbles; Neoplasms, Experimental; Ultrasonic Waves

2020
Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation.
    Aging, 2020, 02-24, Volume: 12, Issue:4

    Topics: Animals; Antineoplastic Agents; Carcinogenesis; Castration; Disease Models, Animal; Docetaxel; Heterografts; Humans; Male; Mice; Prostatic Neoplasms

2020
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
    Neurotoxicity research, 2020, Volume: 38, Issue:1

    Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve

2020
Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    Journal of nanobiotechnology, 2020, Mar-12, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Disease Models, Animal; Docetaxel; Drug Carriers; Fatty Acids; Female; Hexoses; Inhibitory Concentration 50; Lipids; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Particle Size; Poloxamer

2020
CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 27

    Topics: AC133 Antigen; Animals; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Gold; Heterografts; Humans; Indocyanine Green; Male; Mice; Molecular Targeted Therapy; Multimodal Imaging; Nanoparticles; Photochemotherapy; Photothermal Therapy; Prostatic Neoplasms, Castration-Resistant

2020
Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Molecular pharmaceutics, 2020, 07-06, Volume: 17, Issue:7

    Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Disease Models, Animal; Docetaxel; Drug Carriers; Drug Compounding; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Permeability; Rats; Rats, Sprague-Dawley; Skin; Swine; Tissue Distribution; Transplantation, Homologous; Treatment Outcome; Tumor Burden

2020
Melatonin Administered before or after a Cytotoxic Drug Increases Mammary Cancer Stabilization Rates in HER2/Neu Mice.
    Chemotherapy, 2020, Volume: 65, Issue:1-2

    Topics: Anemia; Animals; Antineoplastic Agents; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Leukopenia; Melatonin; Mice; Mice, Transgenic; Receptor, ErbB-2

2020
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 11-01, Volume: 26, Issue:21

    Topics: Androgens; Animals; Apoptosis; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Docetaxel; Drug Synergism; Epithelial Cells; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Male; Mice; Mice, Knockout; Nitric Oxide; Prostatic Neoplasms, Castration-Resistant; Signal Transduction; Sildenafil Citrate

2020
    Recent patents on anti-cancer drug discovery, 2020, Volume: 15, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Endosomes; Female; Fibrinolytic Agents; Folate Receptor 1; Folic Acid; Heparin; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Micelles; Nanoparticles; Neoplasms; Patents as Topic

2020
Drinking Ice-Cold Water Reduces the Severity of Anticancer Drug-Induced Taste Dysfunction in Mice.
    International journal of molecular sciences, 2020, Nov-25, Volume: 21, Issue:23

    Topics: Animals; Cell Proliferation; Cisplatin; Disease Models, Animal; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Ice; Mice; Taste Disorders; Taxoids; Water

2020
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.
    Nature communications, 2021, 02-01, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aminosalicylic Acids; Animals; Apoptosis; Benzenesulfonates; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Disease Models, Animal; Docetaxel; Humans; Interferons; Male; Mesenchymal Stem Cells; Mice, Knockout; Osteoblasts; Primary Cell Culture; Prostatic Neoplasms; Receptors, Interferon; Recombinant Proteins; RNA, Small Interfering; STAT1 Transcription Factor; STAT3 Transcription Factor; Tibia

2021
Docetaxel chemotherapy response in PC3 prostate cancer mouse model detected by rotating frame relaxations and water diffusion.
    NMR in biomedicine, 2021, Volume: 34, Issue:4

    Topics: Animals; Diffusion; Disease Models, Animal; Docetaxel; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Tumor Burden; Water

2021
Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
    Cancer research, 2021, 04-15, Volume: 81, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Proteins; Cell Movement; Chemotaxis; Clodronic Acid; Disease Models, Animal; Docetaxel; Female; Galectins; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Paclitaxel; Pain Perception; Peripheral Nervous System Diseases; Prospective Studies; Rats; Schwann Cells; Sciatic Nerve; Up-Regulation

2021
Simultaneous sentinel lymph node computed tomography and locoregional chemotherapy for lymph node metastasis in rabbit using an iodine-docetaxel emulsion.
    Oncotarget, 2017, Apr-18, Volume: 8, Issue:16

    Topics: Animals; Disease Models, Animal; Docetaxel; Drug Stability; Emulsions; Iodine; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasms; Particle Size; Rabbits; Sentinel Lymph Node; Taxoids; Tomography, X-Ray Computed; Treatment Outcome

2017
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
    Journal of molecular medicine (Berlin, Germany), 2017, Volume: 95, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Phenyl Ethers; Phenylurea Compounds; Prognosis; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; STAT3 Transcription Factor; Taxoids; Transcription, Genetic; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
    Breast cancer research and treatment, 2017, Volume: 165, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Female; Fingolimod Hydrochloride; Humans; Lymphopenia; Mice; Nanoparticles; Neoplasm Metastasis; Neoplasm Staging; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays

2017
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer.
    Scientific reports, 2017, 07-19, Volume: 7, Issue:1

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Liberation; Humans; Lipids; Male; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Nanoparticles; Neoplasm Metastasis; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms

2017
Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach.
    International journal of biological macromolecules, 2018, Volume: 108

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Cell Survival; Chromatography, High Pressure Liquid; Colloids; Disease Models, Animal; Docetaxel; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Mice; Nanoparticles; Particle Size; Polyesters; Spectroscopy, Fourier Transform Infrared; Taxoids; Vitamin E; X-Ray Diffraction; Xenograft Model Antitumor Assays

2018
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.
    Journal of experimental & clinical cancer research : CR, 2017, Nov-15, Volume: 36, Issue:1

    Topics: Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; China; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Humans; Male; Microinjections; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Pyridines; Stomach Neoplasms; Taxoids; Translational Research, Biomedical; Treatment Outcome; Zebrafish

2017
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel.
    Journal of experimental & clinical cancer research : CR, 2017, Dec-08, Volume: 36, Issue:1

    Topics: Aged; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Gene Silencing; Humans; Male; Mice; MicroRNAs; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Taxoids; Transfection; Up-Regulation; Xenograft Model Antitumor Assays

2017
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Fibrosarcoma; Histocompatibility Antigens Class I; Immunotherapy; Male; Methylcholanthrene; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Polysaccharides

2018
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
    Cancer biology & therapy, 2018, 07-03, Volume: 19, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Carriers; Emulsions; Endocytosis; Female; Folate Receptor 1; Folic Acid; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Imaging; Nanoparticles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Theranostic Nanomedicine

2018
Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity.
    Molecular neurobiology, 2019, Volume: 56, Issue:3

    Topics: Animals; Antineoplastic Agents; Cognition; Cognition Disorders; Cyclophosphamide; Cytokines; Dendritic Spines; Disease Models, Animal; Docetaxel; Doxorubicin; Hippocampus; Magnetic Resonance Imaging; Maze Learning; Mice; Neuronal Plasticity; Neurons

2019
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 12-15, Volume: 24, Issue:24

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Black or African American; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Staging; Polycomb Repressive Complex 1; Prostatic Neoplasms; White People; Zebrafish

2018
Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
    Food & function, 2018, Nov-14, Volume: 9, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Disease Models, Animal; Docetaxel; Female; Gene Expression Regulation; Ginsenosides; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Panax; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Xenograft Model Antitumor Assays

2018
Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
    International journal of oncology, 2018, Volume: 53, Issue:5

    Topics: Animals; Antineoplastic Agents; Bystander Effect; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Disease Models, Animal; Docetaxel; Humans; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Neoplasms; Phenotype; Tumor Necrosis Factor-alpha

2018
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model.
    Vascular pharmacology, 2019, Volume: 115

    Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortitis; Apoptosis Regulatory Proteins; Atherosclerosis; Cell Death; Cell Proliferation; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Docetaxel; Drug Compounding; Fibrillar Collagens; Inflammation Mediators; Lipids; Male; Nanoparticles; Plaque, Atherosclerotic; Proliferating Cell Nuclear Antigen; von Willebrand Factor

2019
Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2019, Volume: 299, Issue:6

    Topics: Adenosine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Disease Models, Animal; Docetaxel; Female; Humans; Mice; Tetraspanins

2019
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.
    Nature biomedical engineering, 2019, Volume: 3, Issue:4

    Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Humans; Liposomes; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Receptor, EphA2; Taxoids; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays

2019
Dynamic contrast enhanced‑magnetic resonance imaging for the early evaluation of the response to docetaxel in rats with epithelial ovarian cancer.
    Oncology reports, 2019, Volume: 41, Issue:6

    Topics: Animals; Carcinoma, Ovarian Epithelial; Contrast Media; Disease Models, Animal; Docetaxel; Female; Humans; Magnetic Resonance Imaging; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley

2019
Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:10

    Topics: Amyloid Precursor Protein Secretases; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Damage; DNA Repair; Docetaxel; Humans; Male; Mice; Prostatic Neoplasms; Receptor, Notch1; Xenograft Model Antitumor Assays

2019
Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 08-15, Volume: 25, Issue:16

    Topics: Animals; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Cell Membrane; Deoxycytidine; Disease Models, Animal; Docetaxel; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Models, Biological; Neoplasms; Protein Binding; Protein Transport; Proto-Oncogene Proteins c-myc; Xenograft Model Antitumor Assays

2019
Treatment with melatonin and selenium attenuates docetaxel-induced apoptosis and oxidative injury in kidney and testes of mice.
    Andrologia, 2019, Volume: 51, Issue:8

    Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Male; Melatonin; Mice; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Selenium; Testicular Diseases; Testis; Treatment Outcome

2019
FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
    EBioMedicine, 2019, Volume: 44

    Topics: Adenocarcinoma of Lung; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatocyte Nuclear Factor 3-alpha; Humans; Kaplan-Meier Estimate; Male; Mice; Models, Biological; Prognosis; Protein Binding; SOXD Transcription Factors; Transcriptional Activation; Xenograft Model Antitumor Assays

2019
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 117

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Gemcitabine; Heterografts; Humans; Indazoles; Liposarcoma; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Pyrimidines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays

2019
Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
    Breast cancer research and treatment, 2019, Volume: 177, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Disease Models, Animal; Docetaxel; Docosahexaenoic Acids; Drug Synergism; Female; Humans; Mice; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2019
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
    Molecular cancer research : MCR, 2019, Volume: 17, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Mice; Transcriptome; Xenograft Model Antitumor Assays

2019
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
    Cancer research, 2013, Apr-15, Volume: 73, Issue:8

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Docetaxel; Female; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Taxoids; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2013
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.
    Oncotarget, 2013, Volume: 4, Issue:2

    Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Cycloleucine; Deoxycytidine; Disease Models, Animal; Disease Progression; Docetaxel; Drug Screening Assays, Antitumor; Female; Gemcitabine; Mice; Mice, Inbred C57BL; Random Allocation; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms

2013
Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jun-01, Volume: 19, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Female; Humans; Melanoma, Experimental; Mice; Microtubule Proteins; Neoplasms; Protein Stability; Taxoids

2013
Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:9

    Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cyclams; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Male; MAP Kinase Signaling System; Mice, Nude; Mice, SCID; Neoplasm, Residual; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, CXCR4; Signal Transduction; Taxoids

2013
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.
    Carcinogenesis, 2013, Volume: 34, Issue:10

    Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Docetaxel; Female; Gemcitabine; Humans; Inhibitory Concentration 50; Neoplasms, Experimental; Paclitaxel; Pancreatic Neoplasms; Stathmin; Stromal Cells; Taxoids; Tubulin; Tumor Burden; Xenograft Model Antitumor Assays

2013
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.
    Cancer research, 2013, Aug-01, Volume: 73, Issue:15

    Topics: Actins; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Mice; Nanoparticles; Stromal Cells; Taxoids; Xenograft Model Antitumor Assays

2013
Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.
    The Journal of urology, 2014, Volume: 191, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Humans; Imidazoles; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms, Castration-Resistant; Quinolines; Taxoids; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
    Immunology and cell biology, 2013, Volume: 91, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bridged Bicyclo Compounds, Heterocyclic; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Disease Progression; Docetaxel; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Epothilones; Growth Inhibitors; Humans; Lactones; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubules; Multiple Sclerosis; Paclitaxel; Taxoids

2013
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
    Journal of translational medicine, 2013, Oct-02, Volume: 11

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cell Line, Tumor; Cell Proliferation; China; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Mutation; Nuclear Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidines; Pyrroles; Stomach Neoplasms; Taxoids; Transcription Factors; Treatment Outcome; Xenograft Model Antitumor Assays

2013
Androgen receptor splice variants determine taxane sensitivity in prostate cancer.
    Cancer research, 2014, Apr-15, Volume: 74, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Nucleus; Disease Models, Animal; Docetaxel; Dynactin Complex; HEK293 Cells; Humans; Male; Mice; Mice, SCID; Microtubule-Associated Proteins; Microtubules; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Protein Structure, Tertiary; Receptors, Androgen; RNA Splicing; Signal Transduction; Taxoids; Transfection; Xenograft Model Antitumor Assays

2014
Efficacy of cabazitaxel in mouse models of pediatric brain tumors.
    Neuro-oncology, 2015, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Female; Humans; Male; Maximum Tolerated Dose; Medulloblastoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neuroectodermal Tumors; Rhabdoid Tumor; Survival Analysis; Taxoids; Teratoma; Treatment Outcome; Xenograft Model Antitumor Assays

2015
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer.
    Molecular cancer therapeutics, 2014, Volume: 13, Issue:12

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Docetaxel; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Insulin Receptor Substrate Proteins; Male; Mice; Orchiectomy; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Proteolysis; Receptor, IGF Type 1; Signal Transduction; Taxoids; Tumor Burden; Tyrphostins; Xenograft Model Antitumor Assays

2014
Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer.
    Theranostics, 2014, Volume: 4, Issue:11

    Topics: Animals; Antineoplastic Agents; Autophagy; Breast Neoplasms; Chloroquine; Dendrimers; Disease Models, Animal; Docetaxel; Drug Carriers; Female; Humans; Lysosomes; MCF-7 Cells; Mice, SCID; Nanoparticles; Phagosomes; Taxoids; Treatment Outcome

2014
Docetaxel inhibits urethral stricture formation, an initial study in rabbit model.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Animals; Collagen; Disease Models, Animal; Docetaxel; Drug Administration Schedule; Male; Pilot Projects; Rabbits; Taxoids; Urethral Stricture

2014
Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
    Molecular medicine reports, 2015, Volume: 11, Issue:4

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Glioblastoma; Humans; Mice; Micelles; Particle Size; Peptides, Cyclic; Polyethylene Glycols; Polymers; Spheroids, Cellular; Taxoids; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015
Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.
    European urology, 2015, Volume: 67, Issue:6

    Topics: Aged; Animals; Antineoplastic Agents; Benzamides; Disease Models, Animal; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Humans; Ki-67 Antigen; Male; Mice; Middle Aged; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Taxoids; Treatment Outcome

2015
Docetaxel-encapsulating small-sized polymeric micelles with higher permeability and its efficacy on the orthotopic transplantation model of pancreatic ductal adenocarcinoma.
    International journal of molecular sciences, 2014, Dec-17, Volume: 15, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Compounding; Female; Humans; Mice; Micelles; Pancreatic Neoplasms; Permeability; Polymers; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays

2014
Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma.
    Brain, behavior, and immunity, 2015, Volume: 48

    Topics: Animals; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Female; Mice; Mice, Inbred BALB C; Substance P; Taxoids; Treatment Outcome

2015
Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram.
    Behavioural brain research, 2015, Sep-01, Volume: 290

    Topics: Animals; Antineoplastic Agents; Behavior, Animal; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Disease Models, Animal; Docetaxel; Male; Memory Disorders; Phosphodiesterase 4 Inhibitors; Rats; Rats, Wistar; Rolipram; Spatial Memory; Taxoids

2015
Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model.
    Anticancer research, 2015, Volume: 35, Issue:6

    Topics: Animals; Cancer Vaccines; Disease Models, Animal; Docetaxel; Humans; Immunotherapy; Interleukin-11; Interleukin-6; Killer Cells, Natural; Male; Mice; Neoplastic Stem Cells; Prostatic Neoplasms; Recombinant Fusion Proteins; Taxoids

2015
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Proliferation; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Female; Flow Cytometry; HeLa Cells; Humans; Immunoenzyme Techniques; Mice; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Survival Rate; Taxoids; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015
Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:1

    Topics: Alanine; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Docetaxel; Drug Interactions; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolones; Radiotherapy; Stomatitis; Taxoids

2015
Nanoparticle biointerfacing by platelet membrane cloaking.
    Nature, 2015, Oct-01, Volume: 526, Issue:7571

    Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Blood Vessels; Cell Membrane; Collagen; Complement Activation; Coronary Restenosis; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Humans; Macrophages; Male; Mice; Nanoparticles; Platelet Adhesiveness; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Taxoids; Unilamellar Liposomes; Vancomycin

2015
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Feb-01, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; Biomarkers; CD24 Antigen; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hyaluronan Receptors; Male; Mice; Neoplastic Stem Cells; Prostatic Neoplasms, Castration-Resistant; Protein Binding; ras GTPase-Activating Proteins; Taxoids; Tumor Stem Cell Assay; Wnt Signaling Pathway

2016
Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer.
    The AAPS journal, 2016, Volume: 18, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Docetaxel; Female; Mice; Mice, Knockout; Ritonavir; Taxoids; Treatment Outcome; Tumor Burden

2016
Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
    Cancer medicine, 2016, Volume: 5, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mice; Neoplastic Stem Cells; Prostatic Neoplasms; STAT3 Transcription Factor; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016
Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Disease Models, Animal; Docetaxel; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Humans; I-kappa B Kinase; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Neoplastic Stem Cells; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Taxoids; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2016
Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.
    Scientific reports, 2016, 06-08, Volume: 6

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Folic Acid; G2 Phase Cell Cycle Checkpoints; Humans; Ligands; Male; Mice; Molecular Imaging; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Polyethylene Glycols; Polymers; Taxoids; Xenograft Model Antitumor Assays

2016
Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.
    Pharmaceutical research, 2016, Volume: 33, Issue:10

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Female; Humans; Hyperthermia, Induced; Liposomes; Male; Mice; Mice, Nude; Prostatic Neoplasms; Random Allocation; Survival Rate; Taxoids; Temperature; Tissue Distribution; Xenograft Model Antitumor Assays

2016
Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
    Oncogene, 2016, 11-24, Volume: 35, Issue:47

    Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; HSP27 Heat-Shock Proteins; Humans; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, Parathyroid Hormone, Type 1; Receptors, Androgen; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays

2016
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Molecular cancer, 2016, 11-10, Volume: 15, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; MicroRNAs; Phosphoproteins; Prostatic Neoplasms; RNA Interference; Taxoids; Transcription Factors; Vesicular Transport Proteins; Xenograft Model Antitumor Assays; YAP-Signaling Proteins

2016
Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.
    Scientific reports, 2017, 03-07, Volume: 7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Caco-2 Cells; Disease Models, Animal; Docetaxel; Drug Carriers; Humans; Liposomes; Mice; Taxoids; Treatment Outcome; Vitamin E

2017
The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice.
    BMC cancer, 2017, 03-07, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Models, Animal; Docetaxel; Humans; Male; Mice; Neoplasm Metastasis; Niacinamide; Prostatic Neoplasms; Pyridines; Taxoids

2017
Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
    Archives of otolaryngology--head & neck surgery, 2008, Volume: 134, Issue:7

    Topics: Animals; Antineoplastic Agents; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Injections, Intralesional; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Transplantation; Otorhinolaryngologic Neoplasms; Pilot Projects; Salivary Gland Neoplasms; Taxoids; Tumor Burden; Wound Healing

2008
Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease.
    Breast cancer research and treatment, 2009, Volume: 118, Issue:2

    Topics: Animals; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Disease Models, Animal; Docetaxel; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Taxoids; Xenograft Model Antitumor Assays

2009
Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model.
    Cancer gene therapy, 2009, Volume: 16, Issue:5

    Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Docetaxel; Gene Expression Regulation, Enzymologic; Genetic Vectors; Liver; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; Taxoids; Transaminases

2009
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
    Endocrine-related cancer, 2009, Volume: 16, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Proliferation; Cisplatin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Docetaxel; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays

2009
Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Monitoring; Female; Humans; Injections; Luciferases, Firefly; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pleural Effusion, Malignant; Taxoids; Treatment Outcome

2009
Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
    Journal of the peripheral nervous system : JPNS, 2009, Volume: 14, Issue:1

    Topics: 20-alpha-Dihydroprogesterone; Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Docetaxel; Gene Expression Regulation; Male; Myelin Basic Protein; Myelin P0 Protein; Myelin Proteins; Nerve Fibers; Neural Conduction; Neuroprotective Agents; Pain Threshold; Peripheral Nervous System Diseases; Progesterone; Rats; Rats, Inbred F344; Sciatic Nerve; Taxoids

2009
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.
    The Prostate, 2010, May-01, Volume: 70, Issue:6

    Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Male; Mice; Mice, Nude; Oligoribonucleotides, Antisense; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Telomerase; Xenograft Model Antitumor Assays

2010
Peripheral olfactory sensitivity in rodents after treatment with docetaxel.
    The Laryngoscope, 2010, Volume: 120, Issue:4

    Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Olfactory Mucosa; Olfactory Pathways; Olfactory Perception; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Risk Factors; Taxoids

2010
A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity.
    Biochemical pharmacology, 2010, Aug-15, Volume: 80, Issue:4

    Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Antagonism; Heart Diseases; Male; Mice; Mice, Inbred ICR; Taxoids

2010
Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Taxoids; Time Factors; Treatment Outcome

2010
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
    International journal of cancer, 2011, Jul-01, Volume: 129, Issue:1

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Division; Disease Models, Animal; Docetaxel; Immunohistochemistry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasm Metastasis; Peptides; Receptors, CXCR4; Taxoids; Vascular Endothelial Growth Factor A

2011
Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Time Factors; Treatment Outcome

2011
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.
    Cancer biology & therapy, 2010, Dec-15, Volume: 10, Issue:12

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Endometrial Neoplasms; Female; Gene Expression; Humans; Ki-67 Antigen; Mice; Microvessels; Molecular Targeted Therapy; Neovascularization, Pathologic; Phosphorylation; Prognosis; Receptor Protein-Tyrosine Kinases; Receptor, EphA2; Receptors, Estrogen; Receptors, Progesterone; Survival; Taxoids; Vascular Endothelial Growth Factor A

2010
Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenografts.
    International journal of oncology, 2011, Volume: 38, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Cycle; Cell Survival; Disease Models, Animal; Docetaxel; Female; Humans; Immunoconjugates; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab; Xenograft Model Antitumor Assays

2011
Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2011, Volume: 69, Issue:4

    Topics: Animals; Annexin A5; Breast Neoplasms; Disease Models, Animal; Docetaxel; Mice; Organotechnetium Compounds; Radionuclide Imaging; Taxoids

2011
In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer.
    Biomacromolecules, 2011, Apr-11, Volume: 12, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Chromatography, Gel; Disease Models, Animal; Docetaxel; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Particle Size; Taxoids; Urinary Bladder Neoplasms

2011
Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor
    Cancer biology & therapy, 2011, May-01, Volume: 11, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azo Compounds; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Docetaxel; Female; Humans; Luciferases; Luminescent Agents; Mice; Mice, Nude; Protein Serine-Threonine Kinases; Pyrazoles; Reproducibility of Results; Taxoids; Transfection

2011
Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascites; Biomarkers, Tumor; CA-125 Antigen; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Nude; Mucin-1; Ovarian Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Survival Analysis; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays

2011
Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    The Prostate, 2012, Jun-01, Volume: 72, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Lenalidomide; Male; Mice; Mice, Nude; Prostatic Neoplasms; Taxoids; Thalidomide; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
    Biomaterials, 2012, Volume: 33, Issue:2

    Topics: Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Female; Glycerol; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polymers; Swine; Taxoids; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium

2012
Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.
    Biomaterials, 2012, Volume: 33, Issue:5

    Topics: Animals; Antineoplastic Agents; Carboxymethylcellulose Sodium; Disease Models, Animal; Docetaxel; Drug Screening Assays, Antitumor; Intracellular Space; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasms; Polyethylene Glycols; Polymers; Taxoids; Tissue Distribution; Treatment Outcome

2012
Tumor-targeted drug delivery using MR-contrasted docetaxel - carboxymethylcellulose nanoparticles.
    Biomaterials, 2012, Volume: 33, Issue:15

    Topics: Animals; Carboxymethylcellulose Sodium; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Magnetic Resonance Imaging; Male; Mice; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Staining and Labeling; Subcutaneous Tissue; Taxoids; Tissue Distribution; Treatment Outcome

2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
    Nature, 2012, Mar-18, Volume: 483, Issue:7391

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Genes, p53; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Mutation; Pharmacogenetics; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Randomized Controlled Trials as Topic; ras Proteins; Reproducibility of Results; Taxoids; Tomography, X-Ray Computed; Treatment Outcome

2012
Cancer: Clinical trials unite mice and humans.
    Nature, 2012, Mar-28, Volume: 483, Issue:7391

    Topics: Animals; Benzimidazoles; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Humans; Lung Neoplasms; Pharmacogenetics; Taxoids

2012
Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Adipose Tissue; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Mice; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Small Molecule Libraries; STAT3 Transcription Factor; Taxoids; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2012
Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model.
    The Prostate, 2013, Volume: 73, Issue:9

    Topics: Animals; Bone Neoplasms; Cations; Colloids; Disease Models, Animal; Docetaxel; Ferrosoferric Oxide; Hyperthermia, Induced; Liposomes; Magnetics; Male; Prostatic Neoplasms; Random Allocation; Rats; Rats, Inbred F344; Taxoids

2013
Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2004, Volume: 71, Issue:2

    Topics: Animals; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Female; Flavonoids; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Piperidines; Probability; Radiation Dosage; Radiation-Sensitizing Agents; Sensitivity and Specificity; Survival Rate; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2004
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
    Journal of the National Cancer Institute, 2004, May-19, Volume: 96, Issue:10

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Deoxycytidine; Disease Models, Animal; DNA, Neoplasm; Docetaxel; Doxorubicin; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Floxuridine; Gemcitabine; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Paclitaxel; Proto-Oncogene Proteins; Receptor, ErbB-2; Taxoids; Transplantation, Heterologous; Trastuzumab; Tumor Stem Cell Assay; Up-Regulation; Vinblastine; Vinorelbine

2004
Docetaxel and hyperthermia: factors that modify thermal enhancement.
    Journal of surgical oncology, 2004, Oct-01, Volume: 88, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Fibrosarcoma; Hyperthermia, Induced; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Taxoids

2004
Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh.
    Breast cancer research and treatment, 2005, Volume: 90, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Survival; Cimicifuga; Cisplatin; Cyclophosphamide; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Interactions; Female; Humans; Mammary Neoplasms, Animal; Phytotherapy; Radiotherapy; Taxoids; Tumor Cells, Cultured

2005
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:6

    Topics: Adipocytes; Animals; Breast Neoplasms; Cell Death; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Humans; Interferon-gamma; Interleukin-6; Interleukin-8; Lactones; Mice; Mice, Nude; Neoplasm Metastasis; Sesquiterpenes; Survival Rate; Taxoids; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays

2005
Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2005, Volume: 133, Issue:4

    Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Count; Cholecalciferol; Dendritic Cells; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Interferon-gamma; Lymph Nodes; Mice; Spleen; Stem Cells; T-Lymphocytes; Taxoids; Vitamins

2005
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Cancer research, 2005, Dec-15, Volume: 65, Issue:24

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Ceramides; Disease Models, Animal; Docetaxel; Flow Cytometry; Green Fluorescent Proteins; Humans; Lysophospholipids; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Sphingosine; Taxoids; Tumor Cells, Cultured

2005
Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jan-01, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Castration; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, SCID; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids

2006
Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-01, Volume: 12, Issue:11 Pt 1

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Binding Sites; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; In Situ Hybridization, Fluorescence; Injections, Intravenous; Mice; Mice, Nude; Molecular Conformation; Paclitaxel; Stereoisomerism; Taxoids; Tubulin; Xenograft Model Antitumor Assays

2006
Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Ggamma/T-15 transgenic mouse model of prostate cancer.
    The Prostate, 2006, Oct-01, Volume: 66, Issue:14

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Division; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Flavonoids; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neovascularization, Pathologic; Piperidines; Prostatic Neoplasms; Taxoids; X-Linked Inhibitor of Apoptosis Protein

2006
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-01, Volume: 12, Issue:17

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasms; Oligodeoxyribonucleotides, Antisense; Oligonucleotides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Structure-Activity Relationship; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Transplantation, Heterologous; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays

2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Oct-15, Volume: 12, Issue:20 Pt 1

    Topics: Animals; Antibodies; Apoptosis; Cell Cycle; Disease Models, Animal; Docetaxel; Humans; Male; Orchiectomy; Prostatic Neoplasms; Receptor, IGF Type 1; Taxoids; Transplantation, Heterologous

2006
3'-deoxy-3'-(18)F-fluorothymidine (FLT) positron emission tomography for early prediction of response to chemoradiotherapy--a clinical application model of esophageal cancer.
    Seminars in oncology, 2007, Volume: 34, Issue:2 Suppl 1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Mice; Neoadjuvant Therapy; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome

2007
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jul-01, Volume: 13, Issue:13

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nucleic Acid Hybridization; Oligopeptides; Taxoids; Trastuzumab

2007
Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
    Cancer gene therapy, 2008, Volume: 15, Issue:5

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Disease Models, Animal; Docetaxel; Genetic Therapy; Green Fluorescent Proteins; Humans; Male; Mice; Prostatic Neoplasms; Taxoids; Telomerase

2008
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
    Journal of the National Cancer Institute, 2008, Mar-05, Volume: 100, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Docetaxel; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoblotting; Immunohistochemistry; Interleukin-8; Kaplan-Meier Estimate; Liposomes; Mice; Mice, Nude; Microcirculation; Middle Aged; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphorylation; Prognosis; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Taxoids; Up-Regulation

2008
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.
    The Prostate, 2008, Jun-01, Volume: 68, Issue:8

    Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Male; Mice; Mice, SCID; Prostatic Neoplasms; Radiography; RANK Ligand; Recombinant Fusion Proteins; Taxoids

2008
The common marmoset as a target preclinical primate model for cytokine and gene therapy studies.
    Blood, 1999, May-01, Volume: 93, Issue:9

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Cells; Callithrix; Cells, Cultured; Cytokines; Disease Models, Animal; DNA, Viral; Docetaxel; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphocytes; Paclitaxel; Polymerase Chain Reaction; Retroviridae; Stromal Cells; Taxoids; Transplantation, Autologous

1999
Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
    Bioorganic & medicinal chemistry letters, 1999, Jun-21, Volume: 9, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Drug Screening Assays, Antitumor; Humans; Melanoma, Experimental; Mice; Neoplasm Transplantation; Paclitaxel; Prodrugs; Solubility; Structure-Activity Relationship; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Water

1999
Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease Models, Animal; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Floxuridine; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Paclitaxel; Taxoids; Thymidine Phosphorylase; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays

2001
A preclinical model for experimental chemotherapy of human head and neck cancer.
    International journal of oncology, 2001, Volume: 18, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Ifosfamide; Methotrexate; Mice; Mice, Nude; Paclitaxel; Survival Rate; Taxoids

2001
A mouse model for the study of factors affecting angiogenesis.
    Pharmacology & toxicology, 2002, Volume: 90, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Humans; Ifosfamide; Injections, Subcutaneous; Mice; Neovascularization, Pathologic; Paclitaxel; Prostheses and Implants; Surgical Sponges; Taxoids

2002